|

Pacemaker Implantation Following Transcatheter Tricuspid Valve Replacement

RECRUITINGSponsored by Deutsches Herzzentrum Muenchen
Actively Recruiting
SponsorDeutsches Herzzentrum Muenchen
Started2024-01-01
Est. completion2025-01-31
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06814574

Summary

Transcatheter tricuspid valve replacement (TTVR) is associated with a high risk of third-degree atrioventricular block (AVB). However, the optimal pacemaker management following TTVR remains unclear. This study aims to identify an optimal therapeutic approach for pacemaker implantation in patients undergoing TTVR.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Transcatheter Tricuspid Valve Replacement

Exclusion Criteria:

* no defined exclusion criteria

Conditions3

AV Block CompleteHeart DiseaseTricuspid Regurgitation (TR)

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.